1st International Congress of
Gynecological Oncology

26-27 March 2020,
Bucharest, Romania

Scientific program

Thursday 26.03.2020

08:30-09:00
Opening ceremony

Breast cancer
Chairs: M. Untch, D. Median

09:00-09:20
Hereditary breast and ovarian cancer.
F. Nedelea
09:25-09:45
New insights into surgical treatment of breast cancer.
Al Blidaru
09:50-10:10
Treatment landscape of advanced hormone positive breast cancer patients.
M. Untch
10:15-10:25
Targeted therapies and new insight in the therapy of HER2-positive breast cancer patients.
M. Dediu
10:30-10:40
Coffee break
10:40-10:55
Role of neoadjuvant treatment triple negative breast cancer.
N. Gales
10:55-11:10
Treatment options for triple negative metastatic breast cancer
M. Untch
11:15-11:35
PARPinhibition in breast cancer patients.
D. Median
11:40-12:00
Treatment of bone metastatic disease.
G. Kacso
12:05-12:20
Breast cancer and pregnancy
AM Panaitescu
12:25-12:45
Trophoblastic disease: treatment strategies.
M. Seckl
12:45-13:45
Lunch

Cervical cancer
Chairs: P. Wimberger, Gh. Peltecu

13:45-14:05
From angiogenesis blockade to checkpoint inhibition in cervical cancer.
D. Lorusso
14:10-14:30
Cervical cancer screening landscape in 2019.
M. Gultekin
14:35-14:55
Cervical cancer prevention.
A. Rancea
15:00-15:20
Role of minimal invasive surgery in cervical cancer.
P. Wimberger
15:25-15:45
Defining the best treatment for locally advanced cervical cancer.
P. Achimas
15:50-16:05
Coffee break

Immune therapies in gynecological oncology
Chairs: L. Kandalaft, O. Dorigo

16:05-16:25
Immunology and role of tumor microenvironment in gynecological cancers
O. Dorigo
16:30-16:50
Principles of cellular and immunotherapies in gynecologic oncology.
L. Kandalaft
16:55-17:15
Immune checkpoint blockade in gynecological cancers
D. Stanculeanu
17:20-17:40
Radiotherapy to boost the immune system, and its role in gynecological cancers?
AL Grosu
17:45-18:05
Diagnosis and management of immunotherapy toxicities.
EI Braicu
19:30
Welcome cocktail

Friday, 27.03.2020

A pathway to personalised care in ovarian cancer

08:45-09:00
Prevalence of BRCA mutations and correlations with clinical characteristics in patients with ovarian cancer in Romania (PREDICT)
D. Stanculeanu
09:00-09:15
Rationale for using Parp inhibitors in ovarian cancer patients and Long term follow up results in patients treated with olaparib.
J. Ledermann

09:15-09:30
National strategies for genetic testing for ovarian cancer patients.
TBC

Ovarian Cancer
Chairs: EI Braicu, J. Sehouli

09:30-09:50
Role of Lymph Node dissection in primary ovarian cancer.
J. Sehouli
09:55-10:15
HIPEC: Hype or hope?
C. Fotopoulou
10:20-10:40
PARP inhibition - when is the right time?
J. Ledermann
10:45-11:05
Mechanism of resistance to PARP inhibitors?
C. Gourley
11:05-11:20
Coffee break
11:20-11:40
DNA repair interfering therapies beyond PARPi.
N. Concin
11:40-12:00
Antiangiogenesis – how do we select the timepoint, schedule and population?
S. Pignata
12:05-12:25
Gynecological sarcoma: treatment landscape in 2019.
R. Chekerov

Endometrial and rare cancers
Chairs: H. Gabra, D. Stanculeanu

12:30-12:50
Sentinel node biopsy in endometrial cancer.
O. Dorigo
12:55-13:15
Molecular subtypes of endometrial cancer and their application in clinical decisions.
A. Mustea
13:20-14:50
Lunch and Poster session
14:50-15:20
Personalized medicine for gynecologic cancers and breast cancer – are we there yet?
EI Braicu; G. Iancu
15:25-15:45
Current and future directions in endometrial cancer treatment.
L. Hanker
15:50-16:10
Germ cell tumors of the ovary: diagnosis, prevalence and treatment landscape.
Gh. Peltecu
16:15-16:45
Role of surgery in relapsed ovarian cancer.
A. Du Bois
16:45-17:25
Cancer Sociology : Coordinated reprogramming of the tumor and its microenvironment for therapeutic benefit.
H. Gabra

Award for best three posters and closing remarks
Chairs: EI Braicu, Gh Peltecu, J. Sehouli

Saturday, 28 March 2020
Program Patients Advocacy Day

08:00-08:30
Welcome breakfast
08:30-08:30
Welcome
M. Gultekin, EI Braicu
08:30-08:45
ENGAGe
M. Gultekin and S. Ene

Scientific session with international experts. Part I
Chairs: EI Braicu, J. Sehouli

08:45-08:55
Risk of hereditary ovarian and breast cancer. Genetic counselling.
EI Braicu
08:55-09:10
Bad cop, good cop in nutrition.
A. Rotmann
09:10-09:25
Role of surgery in ovarian cancer.
J. Sehouli
09:25-09:40
Relapsed Ovarian Cancer 2020
A. Du Bois
09:40-10:00
Discussion
10:00-10:15
Coffee break.

Scientific session with international experts. Part II
Chairs: Gh. Peltecu, L. Kandalaft

10:15-10:30
What should we know about PARP inhibitors?
M. Untch
10:30-10:45
Antiangiogenesis – is this working?
C. Nitipir
10:45-11:00
Immune therapies – miracle or reality?
L. Kandalaft
11:00-11:15
How can art help me?
A. Pirmorady
11:15-11:30
Challenges in cervical cancer treatment
O. Trifanescu
11:30-12:00
Discussion

12:00-12:10
Farewell
EI Braicu, Gh. Peltecu